/Investor DB

ShangBay Capital LLC — 2023 Investments

3 investments dated 2023 · listed companies and verified rows first · show all

Luminopialuminopia.comin𝕏Seed · Jun 2023 · $16M✓ verified

Luminopia is an FDA-cleared binocular therapy for amblyopia in children aged 4-12 that uses a VR headset to stream the child's favorite TV shows as treatment, replacing traditional eye patches.

BiotechDigital HealthHealthtechMedical DevicesAspen, US

Scott Xiao(Co-Founder & CEO)inDean Travers(Co-Founder)inBrion Raymond(CBO)inDrew Mowery(VP of Commercial Strategy)inHank Wu(COO)inSunny Atwal(VP of Engineering)in

Co-investorsBantam GroupCollaborative FundGood FriendsNXT VenturesSony Ventures CorporationUS Venture Partners+1 more

Solenic Medicalsolenic.cominJun 2023

Solenic Medical is a medical company; this page is an investor contact form and does not describe the company's products or technology in detail.

Medical DevicesCollege Station, US

James Y Lancaster(Executive Officer, Director)in

BoardJohn Hodock(Director)Robert Calvin Goforth(Director)

Co-investorsSugati VenturesJohnson & Johnson Innovation – JJDC

Window Therapeuticswindowtx.comin𝕏Sep 2023

Window Therapeutics is a biotechnology company developing therapeutics for cancer and other life-threatening diseases, based on its bottle-brush-analogue-macromonomer (BAM) technology.

BiotechDeep TechHealthtechBoston, US

James Lu(Director)Jeremiah Johnson(Founder (based on BAM technology from his MIT lab))Lusong Luo(Director)Chih-Kao Hu(Executive Officer, Director)

BoardKenneth C. Anderson(Professor, Researcher and Clinician, Harvard Medical School & DFCI)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.